Biz Money; With Expansion Nearing Completion, ImmuCell Girds for FDA Vetting
VOL. XXIII, NO. XXVII
ImmuCell Corp is a publicly traded animal health company and they are gearing up for more growth with a new $20.8 Million Portland production site. They plan to make an antimicrobial substance to treat mastitis in dairy cows and will be applying for FDA approval for the new product.
ImmuCell Corp., FDA Approval, Mastitis, Dairy Cows
"Biz Money; With Expansion Nearing Completion, ImmuCell Girds for FDA Vetting" (2017). Maine News Index – MaineBiz. 7199.